Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-12 06:06 am Purchase | 13D | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 4,031,370 10.700% | 77,500 (+1.96%) | View |
| 2024-12-10 06:06 am Purchase | 13D | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 3,953,870 10.500% | 115,000 (+3.00%) | View |
| 2024-12-05 07:45 am Purchase | 13D | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 3,838,870 10.000% | 1,135,935 (+42.03%) | View |
| 2024-05-24 08:58 am Purchase | 13D | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 2,702,935 14.700% | 1,172,935 (+76.66%) | View |
| 2022-07-18 09:00 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | L5 Capital Inc. | 1,170,000 10.590% | 570,000 (+95.00%) | View |
| 2022-06-29 09:00 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | L5 Capital Inc. | 600,000 5.400% | 600,000 (New Position) | View |
| 2021-09-07 4:05 pm Unchanged | 13D | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 1,530,000 10.000% | 0 (Unchanged) | View |
| 2021-08-04 09:43 am Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 1,530,000 10.000% | 805,000 (+111.03%) | View |
| 2021-06-28 4:15 pm Purchase | 13G | BRIACELL THERAPEUTICS CORP BCTX | L5 Capital Inc. | 725,000 5.010% | 725,000 (New Position) | View |